How tranScrip CEO Marcin Mankowski is ‘driving forward’ drug innovation and development 24-May-2023 By Isabel Cameron tranScrip is a contract drug development organisation supporting the entire lifecycle of medicines and medical devices.
Harbour BioMed inks agreement for ‘next generation biologic discovery’ 30-May-2019 By Maggie Lynch Harbour BioMed and an unnamed ‘leader’ in immunology enter license agreement to develop, discover, and commercialize biologic therapeutics using the former’s transgenic mouse platform.